2seventy bio (TSVT) Stock Chart & Stock Price History → How to Play the AI and Crypto Markets in One Swing (From Weiss Ratings) (Ad) Free TSVT Stock Alerts $4.87 +0.14 (+2.96%) (As of 04:28 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media 2seventy bio Stock Price Performance5 Day Performance+7.99%1 Month Performance-5.12%3 Month Performance-18.02%6 Month Performance+103.00%Year-To-Date Performance+10.77%1 Year Performance-59.36% Receive TSVT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 2seventy bio and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Chaikin AnalyticsWall Street legend who predicted 2021 tech crash issues new warningPeople around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch his stock warning right here, 100% free of charge TSVT Stock Chart for Wednesday, May, 15, 2024 TSVT Chart by TradingView 2seventy bio Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/14/2024$4.49$4.73+5.35%$4.92$4.51506,398 shs$243.12 million05/13/2024$4.38$4.49+2.51%$4.60$4.44229,942 shs$230.79 million05/10/2024$4.44$4.38-1.24%$4.49$4.24403,716 shs$225.13 million05/09/2024$4.48$4.44-1.00%$4.56$4.32478,496 shs$227.96 million05/08/2024$4.96$4.48-9.68%$5.07$4.46700,261 shs$230.27 million05/07/2024$4.95$4.96+0.20%$5.10$4.93363,320 shs$254.94 million Get the Latest News and Ratings for TSVT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 2seventy bio and its competitors with MarketBeat's FREE daily newsletter. 05/06/2024$4.76$4.95+3.99%$4.97$4.75453,359 shs$244.69 million05/03/2024$4.93$4.76-3.45%$5.13$4.60598,347 shs$244.66 million05/02/2024$4.60$4.93+7.17%$4.96$4.67568,626 shs$253.40 million05/01/2024$4.56$4.60+0.88%$4.80$4.54761,440 shs$236.44 million04/30/2024$4.59$4.56-0.65%$4.62$4.43528,887 shs$234.38 million04/29/2024$4.26$4.59+7.87%$4.66$4.19668,200 shs$235.93 million04/26/2024$4.29$4.26-0.82%$4.38$4.14311,542 shs$218.32 million04/25/2024$4.27$4.29+0.47%$4.35$3.443.72 million shs$220.12 million04/24/2024$4.63$4.27-7.78%$4.74$4.21470,190 shs$219.09 million04/23/2024$4.65$4.63-0.43%$4.86$4.60292,107 shs$237.57 million04/22/2024$4.52$4.65+2.88%$4.72$4.35406,346 shs$238.60 million04/19/2024$4.64$4.52-2.59%$4.76$4.46608,615 shs$231.92 million04/18/2024$5.06$4.64-8.30%$5.07$4.61713,993 shs$238.08 million04/17/2024$4.86$5.06+4.12%$5.20$4.87895,858 shs$259.63 million04/16/2024$4.99$4.86-2.51%$4.95$4.70932,484 shs$249.37 million04/15/2024$5.04$4.99-1.09%$5.12$4.95393,282 shs$255.78 million04/12/2024$5.52$5.04-8.70%$5.50$4.96797,376 shs$258.60 million04/11/2024$5.23$5.52+5.54%$5.52$5.11712,991 shs$283.23 million04/10/2024$5.63$5.23-7.10%$5.50$5.19849,807 shs$268.35 million04/09/2024$5.51$5.63+2.18%$5.81$5.461.35 million shs$288.88 million04/08/2024$4.92$5.51+11.99%$5.72$5.051.72 million shs$282.72 million04/05/2024$5.01$4.92-1.80%$5.90$4.924.39 million shs$252.45 million04/04/2024$4.98$5.01+0.60%$5.12$4.91482,644 shs$257.07 million04/03/2024$4.94$4.98+0.81%$5.16$4.78621,792 shs$255.52 million04/02/2024$5.79$4.94-14.68%$5.70$4.931.08 million shs$253.47 million04/01/2024$5.35$5.79+8.22%$5.99$5.391.25 million shs$297.09 million03/29/2024$5.35$5.35$5.56$5.241.10 million shs$274.51 million03/28/2024$5.38$5.35-0.56%$5.56$5.241.09 million shs$274.51 million03/27/2024$4.96$5.38+8.47%$5.40$4.811.10 million shs$276.05 million03/26/2024$4.90$4.96+1.22%$5.64$4.901.97 million shs$254.50 million03/25/2024$5.13$4.90-4.48%$5.57$4.871.52 million shs$251.42 million03/22/2024$4.99$5.13+2.81%$5.26$4.90895,469 shs$263.22 million03/21/2024$4.54$4.99+9.91%$5.03$4.511.60 million shs$256.04 million03/20/2024$4.49$4.54+1.11%$4.61$4.29907,747 shs$232.95 millionHe cracked the code to crypto… (Ad)Juan Villaverde has cracked the code to crypto.Click now for the best way into the newest AI projects03/19/2024$4.19$4.49+7.16%$4.66$4.012.73 million shs$230.39 million03/18/2024$4.01$4.19+4.49%$5.20$3.956.90 million shs$214.99 million03/15/2024$3.96$4.00+1.01%$4.39$3.88940,950 shs$205.24 million03/14/2024$4.01$3.96-1.25%$4.02$3.85541,588 shs$203.19 million03/13/2024$4.73$4.01-15.22%$4.40$3.881.83 million shs$205.75 million03/12/2024$4.58$4.73+3.28%$4.84$4.48729,081 shs$242.70 million03/11/2024$4.72$4.58-2.97%$4.87$4.401.01 million shs$235 million03/08/2024$5.38$4.72-12.27%$5.85$4.563.76 million shs$238.93 million03/07/2024$5.67$5.38-5.11%$5.82$5.36803,303 shs$272.34 million03/06/2024$5.79$5.67-2.07%$5.89$5.41974,953 shs$287.02 million03/05/2024$5.42$5.79+6.83%$5.91$5.291.07 million shs$293.12 million03/04/2024$5.64$5.42-3.90%$5.69$5.23676,866 shs$274.36 million03/01/2024$5.20$5.64+8.46%$5.70$5.24666,048 shs$285.50 million02/29/2024$5.44$5.20-4.41%$5.53$5.20487,184 shs$263.25 million02/28/2024$5.96$5.44-8.72%$6.00$5.42642,247 shs$275.37 million02/27/2024$5.50$5.96+8.36%$5.98$5.50946,975 shs$301.70 million02/26/2024$5.39$5.50+2.04%$5.60$5.33498,838 shs$278.41 million02/23/2024$5.25$5.39+2.67%$5.45$5.12428,729 shs$272.84 million02/22/2024$5.58$5.25-5.91%$5.61$4.99922,296 shs$265.76 million02/21/2024$5.84$5.58-4.45%$5.85$5.55516,465 shs$282.46 million02/20/2024$6.00$5.84-2.67%$6.40$5.771.08 million shs$295.62 million02/19/2024$6.00$6.00$6.13$5.69767,500 shs$303.75 million02/16/2024$5.77$6.00+3.99%$6.13$5.76767,308 shs$303.72 million02/15/2024$5.53$5.77+4.34%$6.04$5.52655,456 shs$292.11 million02/14/2024$5.65$5.53-2.12%$5.84$5.52600,393 shs$279.93 million Related Companies: G1 Therapeutics Stock Chart Omeros Stock Chart Foghorn Therapeutics Stock Chart Pyxis Oncology Stock Chart Aldeyra Therapeutics Stock Chart uniQure Stock Chart Puma Biotechnology Stock Chart Generation Bio Stock Chart Design Therapeutics Stock Chart Ovid Therapeutics Stock Chart Receive TSVT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for 2seventy bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TSVT) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaBill Clinton Backing Biden Replacement???The Freeport SocietyAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 2seventy bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.